HIGHLY HOMOLOGOUS REPEATS IN CRI
forms differing by increments of^-40,000-50,000 Mr. The two most common forms, the F and S allotypes, also termed the A and B allotypes, have M,. of 250,000 and 290,000 (19, 20) , respectively, and two rarer forms have M, of 210,000 and >290,000 (21, 22) . These differences apparently represent variations in the polypeptide chain of CRI because they were not abolished by treatment of purified receptor protein with endoglycosidase F (20) and they were observed when receptor allotypes were biosynthesized in the presence of tunicamycin (23) . All four CR1 allotypes have Cab-binding activity, indicating that insertion or deletion of these relatively large peptide segments does not destroy the ligand binding site (19) (20) (21) (22) .
Additional evidence for an unusual structure for CRI was the finding that two nonoverlapping restriction fragments of a CRI cDNA crosshybridized under conditions of high stringency (24) . This indication of repetitive coding sequences was supported by the observation that both cDNA probes hybridized to multiple restriction fragments of genomic DNA, most of which were common to both probes (24) . In addition, the CR 1 gene has been shown recently to have repetitive intervening sequences by the demonstration of crosshybridization of a genomic probe lacking coding sequences to several genomic restriction fragments (25) . Further, DNA from an individual having the larger S allotype had an additional restriction fragment hybridizing to this genomic probe when compared with DNA from an individual having the F allotype, suggesting that duplication of genomic sequences occurred in association with the higher molecular weight CRI allele (25) .
In the present study, the repetitive unit of CRI was defined by sequencing 5 .5 kb of tonsillar CRI cDNA . Three tandem, direct repeats of 1 .35 kb were found that encode 50-kD peptide segments, termed long homologous repeats (LHR).' Each LHR is composed of seven short consensus repeats (SCR) that are characteristic of C3/C4 binding proteins .
Materials and Methods
Isolation and Sequence of CRI Tryptic Peptides. CRI was purified from washed human erythrocyte membranes by sequential Matrex Red A and YZ-I mAb affinity chromatography (26) . Tryptic peptides were prepared and isolated by sequential gradient and isocratic reverse-phase HPLC as described (24) . Tryptic peptide analysis was performed with a 470A Protein Sequencer (Applied Biosystems, Inc., Foster City, CA), and analysis of each degradative cycle was achieved using a 120 PTH-amino acid analyzer (Applied Biosystems, Inc.) .
Isolation ofcDNA Clones and Genomic Clones. A cDNA library was constructed in Xgtl l from human tonsillar poly(A)' RNA as described (24) . By RNA blot hybridization, the tonsil donor was homozygous for the F allele of CR1 (24) . The cDNA was selected on an agarose gel to include fractions between 2 and 7 kb before the cloning steps. The initial complexity of the library was 4.5 X 106 recombinants per 100 ng cDNA and the library was amplified in Escherichia coli strain Y1088. The library was screened (27) with CRI probes, CRI-I and CRI-2 (24) , that had been radiolabeled to a sp act of 2-8 X 10 8 cpm/ug by nick translation . Hybridization was performed in 50% formamide, 5X SSC (IX SSC: 15 mM sodium citrate, 150 mM sodium chloride) at 43°C and filters were washed at 60°C in 0.2X SSC, conditions that do not allow the detection of CR2 cDNA 'Abbreviations used in thispaper: C46p, C4-binding protein; LHR, long homologous repeat ; SCR, short consensus repeat. ;== TB7.1
Restriction map of 5 .5 kb of human CR1 cDNA . The black bar indicates the cDNA, restriction sites are H, Hind III ; B, Bam HI ; R, Eco RI ; P, Pst I ; A, Apa I ; S, Sac I ; G, Bg1 II ; K, Kpn I . The cDNA clones from which the sequence was derived are shown below the map . The arrows indicate the direction and extent of sequence analysis by the dideoxynucleotide chain termination method . cDNA clones were oriented on the basis of restriction maps and overlapping sequence identity . The grey portion of clone T9 .4 indicates that this sequence was determined to be an unspliced intervening sequence as described in the text.
clones (28) . Positive clones were plaque-purified twice before restriction mapping and DNA sequence analysis. A genomic library was constructed in EMBL-3 with 15-20-kb fragments produced by partial digestion of human leukocyte DNA with Sam 3AI . The initial complexity was 1 .2 x 106 and the library was amplified in E. coli strain P2392 . The library was also screened with the cDNA probes CR1-1 and CR1-2 (24) . DNA Sequence Analysis. Restriction fragments of the cDNA clones were subcloned in M13mp18 or M13mpl9 and sequenced by the dideoxynucleotide chain termination method (29) . Some clones were sequenced in whole or in part by first creating ordered deletion mutants using exonuclease III (30) . Each region was sequenced on both strands and in most cases each region was sequenced on M13 subclones constructed from two independently isolated cDNA clones (Fig . 1) . Sequence data were analyzed with the University of Wisconsin Genetics Computer Group package (Madison, WI) .
A size-selected tonsillar cDNA library was screened with the CR1-1 and CR1-2 probes obtained from the CR1 cDNA clone, XT8 .3 (24) . 15 positive phage were identified out of 1 .5 x 1,06 recombinants and 13 of these represented distinct clones . 10 were restriction mapped and sequenced in whole or in part by the dideoxynucleotide chain termination method. The cDNA clones were aligned on the basis of overlapping sequence identity ( Fig. 1) and were found to span 5 .5 kb (Fig. 2) . A single long open reading frame was identified beginning FIGURE 2. Nucleotide sequence of 5.5 kb of human CR1 cDNA. The strand corresponding to the mRNA is shown and base number 1 is the first base after the Eco R1 linker in the most 5' clone. The stop codon is underlined . The 110-bp sequence in the box was found between nucleotides 147 and 148 (arrow) and is believed to represent a portion of an intervening sequence as described in the text. at the 5' end of the cDNA clones and extending 4.7 kb downstream to a stop codon. The coding sequence for CR 1 in this library is expected to be 6 kb, based on an estimated 220,000 M,. for the nonglycosylated receptor (20) . Thus, these clones span -80% of the estimated coding sequence .
Clones T49 .1 and T55 .1 contain coding sequence at their 5' ends, indicating that additional 5' coding and noncoding sequences remain to be identified . In the 3' region, the overlapping clones, T8.2, T43 .1 and T87 .1, contain the transmembrane and cytoplasmic regions encoded by an identical sequence in each clone . The clone extending most 3', T8.2, contains 807 by of untranslated sequence without a poly(A) sequence. Clone T8 .3 contains a 91-bp deletion of nucleotides 1,406-1,497 and clone T40 .1 contains a 9-bp deletion of nucleotides 1,498-1,507 relative to the sequences found in clones T6.1 and T55 .1 . These deletions occurred in regions having sequences homologous to 5' splice sites and may represent splicing errors in the mRNA. Clones T49 .1 and T55 .1 contain a 110-bp insertion between nucleotides 147 and 148 of the open reading frame (Fig. 2 ). This sequence is judged to be a portion of an intron because it did not hybridize to blots of tonsillar poly(A)+ RNA, it contains a 5' splice site (31) (Fig.  2) , it is flanked by cDNA sequences in CR1 genomic clones, and it shifts the reading frame . Clone T9.4 contains 0 .88 kb of intervening sequence at the 3' end that does not hybridize to blots of tonsillar poly(A)+ RNA (data not shown) .
Dot matrix analysis of the nucleotide sequence revealed two types of internal homologies (Fig. 3) . The first is represented by the bold, uninterrupted lines that indicate the presence of three tandem, direct, highly homologous repeats of 1 .35 kb. These nucleotide sequences encode the LHRs of CRi . The second type of repeat is represented by the dashed parallel lines that indicate regions of lesser homology . These sequences occur every 190-210 nucleotides and encode the SCRs of CR1 .
The amino acid sequence deduced from the cDNA sequence is presented in Fig . 4 and the three LHRs, designated LHR-B, LHR-C, and LHR-D, are aligned to demonstrate their homology. LHR-B extends from residue 1 through residue 438, LHR-C corresponds to residues 439-891, and LHR-D extends from residue 892 through 1,341 . Residues 451-694 of LHR-C are 99% identical to residues 1-244 of LHR-B, but only 61 % identical to the corresponding residues of LHR-D. In contrast, residues 695-891 of LHR-C are 91 % identical to residues 1,148-1,341 of LHR-D but only 76% identical to the corresponding region of LHR-B. Thus, LHR-C appears to be a hybrid that comprises sequences most homologous to the first halfof LHR-B and the second halfof LHR-D. The LHRs are followed by two SCRs that are not repeated, a 25 residue hydrophobic segment and a 43 amino acid C001-1-terminal region with no sequence homology to the SCRs (Fig. 4) .
The uncloned 1 .3 kb of the expected 6 kb of coding sequence is considered to represent a fourth LHR, LHR-A, based on analysis of tryptic peptides of erythrocyte CR1 . 10 tryptic peptides have sequences identical to the amino acid sequences derived from the cDNA clones (Table I ). In contrast, the sequences of three tryptic peptides are homologous to, but not identical with, the derived amino acid sequences from LHR-B, -C and -D (Table 11 ) . Tryptic peptide 56b differs from the homologous sequence in LHR-B and -C by one residue and from that in LHR-D by 8 of 18 residues . Peptide 42a differs in 3 of 19 residues from the homologous sequence at the LHR-B/-C junction and in 13 of 19 residues from that at the LHR-C/-D junction . It is unlikely that peptide 42a is from the NH2-terminus of LHR-B in which the available derived sequence is identical to that of the corresponding region of LHR-C (Fig. 4) . The recovery of amino acids from the first three cycles in the sequencing of these two unique peptides was 723 ± 321 pmol (mean ± SD) and that of the peptides in Table I corresponding to sequences in LHR-B, LHR-C, or LHR-D was 1,018 ± 545 pmol. Thus, peptides 56b and 42a are probably not derived from the S allotype (frequency 0.2) in which a fifth LHR may be present. The third peptide in Table  II, peptide 9 (1,052 pmol), differs from the homologous sequences of LHR-B, -C, and -D at five of nine residues, suggesting either that a more divergent sequence exists in LHR-A, that there is an SCR in the NH2-terminal region of CR1 that is not part of a long homologous repeat, or that erythrocyte CR 1, from Tryptic peptides from human erythrocyte CRI found in the derived amino acid sequence . The number ranges in the right-hand column indicate the location of the peptide in the derived amino acid sequence . Each dash in peptides 66, 28 and 49 indicates multiple residues were identified at that cycle. The dash in peptide 34b indicates no residue was identified at that cycle. KLICKSTEIN ET AL. Tryptic peptides not found in the derived amino acid sequence . The peptides are aligned with the closest matches from the derived amino acid sequence, the positions of which are given to the right of the sequence. Spaces were introduced to maximize the alignment. A dash indicates that no residue was identified at that position . E/T indicates that both E and T were identified at the fifth cycle in peptide 9.
which the tryptic peptides were derived, contains sequences not found in tonsillar CR1 .
Each LHR comprises seven 60-70 amino acid SCRs that characterize the family of C3 and C4 binding proteins (C4bp) (Fig. 5A) . Maximal homology between the 23 SCRs of CR 1 was observed by introducing spaces in the alignment of the sequences (Fig. 5A) . Altogether, 29 of the average 65 residues in each repeat are conserved. There are six residues that are present in all SCRs: the four half-cystines that are in similar relative positions suggesting that each may be involved in a critical disulfide linkage, and the tryptophan and the second glycine after the second half-cystine (Fig. 5A) . Secondary structure analysis of the sequences between the invariant half-cystines using the algorithm of Chou and Fasman (32) predicted high probability ,8-turn formation and low probability a-helix formation. Sequence analysis of two CR1 genomic clones, 2 .38 ( Fig. 5B ) and 2.46 (data not shown), indicates that SCR-14 ( Fig. 5A) exon and that the COOH-terminus of SCR-23 corresponds to the end of an exon . Thus, the SCRs of CRI may be encoded by separate exons as has been shown for the SCRs of factor B (33) and of the IL-2-R (34). The consensus sequence of the CRI SCRs is compared with the SCRs of the other members o£ the superfamily having this characteristic structure (Fig. 6) . These members include not only proteins having C3/C4 binding function, CR2 (28), C4bp (35) , factor H (36), factor B (37, 38) , and C2 (39, 40) , but also the proteins not known to have this function, the IL-2-R (34), N2-glycoprotein 1 (41), CIr (42) , haptoglobin a chain (43) , and factor XIIIb (44) . The half-cystine residues are invariant in the SCRs of all proteins, except haptoglobin that lacks the third half-cystine . The tryptophan is also invariant with the exception of the fifth SCR in 02GP 1 and two of the repeats in factor XIIIb. Other residues that are conserved but not present in each SCR tend to cluster about the half-cystines. There is only one free thiol group in factor B and C2 (45, 46) , and in the SCRs of 02-glycoprotein I the first half-cystine is disulfide-linked to the third and the second to the fourth (41). In the derived amino acid sequence of CR 1 there are 17 potential sites for Nlinked oligosaccharides and all of them are in the extracellular region (Fig. 5A) . Molecular weight differences between CR 1 synthesized in the presence and absence of tunicamycin (23) and analysis of glucosamine content (47) suggest the presence of only 6-8 N-linked complex oligosaccharides, indicating that all potential sites are not used . For example, the asparagine at residue 263 of the derived amino acid sequence (Fig. 4) was identified in peptide 41c (Table 1) , indicating absence of glycosylation at this site. In contrast, the unidentified amino acid in peptide 34b probably corresponds to a glycosylated asparagine at residue 395.
The only nonrepetitive CR 1 sequences identified in the 5 .5 kb of cDNA are located in the COOH-terminal region . A secondary structure analysis of this region identifies a single 25-residue putative membrane-spanning segment having strong hydrophobic character and high potential for a-helix formation (Fig. 4) . This sequence is immediately followed by four positively charged residues, a characteristic of many membrane proteins . The presumed cytoplasmic region of CR1 comprises 43 residues and contains a six-amino-acid sequence, VHPRTL, which is homologous to the sequence VRKRTL, a site of protein kinase C phosphorylation in the EGF receptor and the erbB oncogene product (48, 49) . There are no tyrosine residues in the cytoplasmic region of tonsillar CR1 . Discussion -80% of the primary structure of the F allotype of CR1 has been obtained by sequencing overlapping cDNA clones . The most unusual structural feature of CR1 observed in this analysis is the presence of tandem, direct LHRs of 450 amino acids, four of which are predicted to occur in the F allotype of CR1 that has an estimated polypeptide chain length of 2,000 residues (20, 47) . Three of the LHRs have been cloned and sequenced while evidence for the existence of the fourth was provided by the analysis of tryptic peptides . Each LHR is comprised of seven SCRs which are the basic structural elements of other C3/C4 binding proteins . The conservation of the four half-cystines per SCR, the probable involvement of the first and third and the second and fourth halfcystines in disulfide linkages (41) and the presence of conserved amino acids such as proline, glycine and asparagine which are frequently found in ,6-turns (50) lead to the proposal that an SCR forms a triple loop structure maintained by disulfide linkages (Fig. 7) . This role for the half-cystine residues is supported by the finding that mildly trypsin-treated CR1 (47) and factor H (51) migrate as intact molecules when analyzed by SDS-PAGE under non-reducing conditions and as multiple tryptic fragments after reduction . This series of tandemly repeated SCRs is predicted to form an elongated structure (Fig. 7) as has been proposed for factor H and for each subunit of human C4bp (51) (52) (53) . Electron microscopic studies of the subunits of C4bp have indicated dimensions of 300 x 30A (53) . As each subunit is composed of eight SCRs (35) , an individual SCR is calculated to be 38 x 30A . Assuming that the SCRs of CR1 have similar dimensions and that the F allotype has 30 SCRs, the receptor could extend as much as 1,140A from the cell membrane . Consistent with this prediction of CR1 structure is the earlier finding that ferritin-labeled antibody bound to CR1 on neutrophils was frequently 500A from the outer leaflet of the plasma membrane (11) . Such an elongated structure of CR 1 would facilitate the interaction of receptor-bearing cells with C3b that has covalently bound to relatively inaccessible sites within immune complexes and microbial cell surfaces . The finding that the SCR is the major, and perhaps only, extracytoplasmic element of CRI provides structural evidence for a close relationship between the receptor and factor H and C4bp, two plasma proteins that are exclusively or predominantly composed of SCRs (35, 36) . CRI was initially isolated as an erythrocyte membrane protein having factor H-like activity after detergent solubilization (17) , and it was found subsequently to have the regulatory functions of factor H and C4bp when residing on the plasma membrane (18) . By analysis of the inheritance of structural polymorphisms of CR 1, factor H, and C4bp, the genes encoding these three proteins were shown to be linked (54) and the locus for this linkage group and for the structurally related receptor, CR2, have been shown recently by in situ hybridization and by the analysis of somatic cell hybrids to be on the long arm of chromosome 1, band q32 (55) . Before the present study, the only evidence for a structural relationship between these proteins was a significant similarity in their amino acid compositions (26) . Therefore, the present finding of at least 23 SCRs in CRI constitutes the direct and formal demonstration of a structural relationship of the receptor with factor H and C4bp (35, 36) , proteins with similar functions, and with the Ba and C2b fragments of factor B and C2 (37) (38) (39) (40) , components that form enzymatic complexes with C3b and C4b, respectively . However, the SCR is also found in several noncomplement proteins (33, (41) (42) (43) (44) (Fig. 6 ), indicating that it does not necessarily represent a C3/C4 binding structure .
Among the proteins having SCRs, CR 1 is unique in having organized this basic structural and genetic unit into the higher order structural unit of the LHR. The genetic basis for this organization has not been defined as yet, although analysis of a 14 .5-kb Bam HI fragment of genomic DNA that is associated with expression of the S allotype has suggested that at least one repeating genomic unit in CR 1 is an extended segment of DNA containing the exons encoding at least five SCRs and their flanking introns (25) . These studies have also suggested that the S allele contains an additional copy of this genomic unit compared with the number present in the F allele . This observation, combined with a tryptic peptide mapping study (56) and the present finding that an LHR represents a peptide of^-40-50 kD predicts the presence in the S allotype (290 kD) of an additional LHR relative to the estimate of four LHRs in the F allotype (M, 250,000) .
In addition to providing evidence for duplication events, the sequences of the LHRs also suggest that conversion events have occurred within the CR 1 gene. LHR-B and -D are 67% identical to each other throughout their length, whereas LHR-C is 99% identical to LHR-B in the NH2-terminal four SCRs and 91 identical to LHR-D in the COON-terminal three SCRs. This organization could not have occurred by a single recombinational event between identical parental alleles in the origin of this hybrid LHR. Rather, the hybrid LHR may have arisen by gene conversion (57) in which sequences in an LHR-C precursor were replaced by sequences present in LHR-B or LHR-D. The near complete identity and precise alignment of homologous sequences in these LHRs (Fig. 4) also may have been maintained by a mechanism involving gene conversion . Analysis of the extent of homology between intervening sequences of those segments of the CRI gene encoding the LHRs should determine whether gene conversion or selection based on functional constraints have strictly limited sequence divergence .
Although a previous study suggested that CRI is monovalent (58), each LHR might represent a single C3b/C4b binding domain, which would make the receptor multivalent and adapted for the binding of complexes bearing multiple molecules of C3b and C4b. Alternatively, distinct LHRs might be responsible for binding C3b and C4b, respectively, providing a structural basis for the combination of factor H and C4bp activities in CRI . Finally, the LHRs of CRI may represent structural domains that serve to extend CRI from the plasma membrane, as suggested by the proposed structural model (Fig. 7) , and as-yetunsequenced SCRs at the NH2-terminal region bind C3b and C4b, as has been found for factor H (51, 59) .
Activation of protein kinase C by phorbol esters induces phosphorylation of CRI in neutrophils, monocytes, and eosinophils (60) and the CRI cytoplasmic domain of 43 amino acids has a sequence that is homologous to a site that is phosphorylated by protein kinase C in the EGF receptor (48, 49) . However, this cytoplasmic sequence, which was found in three independent clones of the tonsillar library, is most likely that of B cell CR 1, which is not phosphorylated after activation of protein kinase C (60) . Determination of the cytoplasmic region of CR I from myelomonocytic cells, which is phosphorylated when these cells are treated with phorbol esters, may provide a basis for this differential phosphorylation of the receptor . 
